In recent years, nonhypertensive pathways have been demonstrated in elastase-induced and CaPO4-induced AAA mouse models, such as homocysteine–AT1 receptor-mediated AAA development and SAMD4A-KDM2B-regulated VSMC phenotype transition in AAA progression [71,72]. This evidence concerns the gene SAMD4A and triple-A syndrome.